HLSQ · Tessera Defense and Homeland Security Inc.

NYSE MKT LLC - Real Time Price • USD

BiomX Inc (HLSQ)

NYSE MKT LLC Biotechnology
Move probability → Options chain →
$0.25 +0.02 (+11.06%)
● At close: October 19 at 4:00:00 PM EDT
$0.21 -0.01 (-4.92%)
🌅 Pre-Market: 8:22:37 AM EDT
DAY'S RANGE $0.25
$0.24 $0.25
52-WEEK RANGE $0.25
$0.20 $1.75

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$5.2M
P/E (TTM1)—
EPS2 (TTM)$-21.44
Div Yield—
Beta3-1.01
Volume1,329
Open0.24
Prev Close0.23
Bid / Ask0.21 / 0.29
Next Earnings 2026-11-10

Analyst Recommendations

Strong buy 0 Buy 0 Hold 3 Sell 1 Strong sell 2

Aggregate ratings for 2026-10-01 (6 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
HLSQ -81.61%
vs S&P 500 -82.24%

Valuation Measures & Ratios

Enterprise Value4—
Forward P/E5—
PEG Ratio6-0.00
Price / Sales (TTM1)—
Price / Book70.44
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-121.19%
Return on Assets (ROA9)-286.58%
Avg Volume (3M)1,587,370
Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short130,329
Change from Prior Settlement+74.89%
% of Float—
Days to Cover (Short Ratio)1.00

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

Not enough positive evidence under the current rules.

Potential concerns

  • Latest SEC filing is Form 8-K, filed 2026-10-19; review it for current changes and risks. SEC EDGAR ↗

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue $332.0K — — — — — — —
Gross profit $97.0K — — — — — — —
Operating income -$5.4M -$1.3M -$8.5M -$7.4M -$7.8M -$11.3M -$9.7M -$6.8M
Net income -$3.8M -$19.1M -$9.2M -$6.0M -$7.7M $9.6M $4.5M -$17.3M
EPS (diluted) $0.37 $7.38 $0.29 $3.66 $6.27 $-0.31 $0.69 $2.78
EPS (basic) $0.37 $7.38 $0.29 $3.66 $6.27 $-0.31 $-0.14 $2.78

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $28.2M $3.3M $5.8M $26.2M $38.0M $45.7M $43.2M $60.0M
Total liabilities $10.6M $4.1M $7.1M — — — — —
Stockholders' equity $10.9M -$881.0K -$1.3M $10.5M $19.2M $24.5M $24.1M $37.9M
Total current assets $2.4M $3.0M $5.6M $8.9M $16.6M $23.5M $20.5M $28.3M
Total current liabilities $10.2M $2.4M $6.4M $5.2M $6.3M $7.0M $8.3M $8.9M
Cash & equivalents $347.0K $1.2M $4.4M $6.9M $14.0M $20.1M $16.9M $23.5M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$1.2M -$5.4M -$4.4M -$7.2M -$6.1M -$8.7M -$6.3M -$8.1M
Investing cash flow -$556.0K -$996.0K $1.0K -$2.0K $58.0K $51.0K -$1.0K -$1.0K
Financing cash flow $905.0K $2.6M $1.3M $54.0K -$29.0K $11.9M -$398.0K $0
Free cash flow — — -$4.4M -$7.2M — — -$6.3M -$8.1M
Capital expenditures — — $0 $2.0K — — $11.0K $10.0K
Depreciation & amortization — — — — — — — —

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding HLSQ as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-07-15 to 2026-03-17

Recent transactions

  • Most recent: Yeganeh Reuven (Director) — Derivative conversion of 530,000 shares on 2026-03-17.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Yeganeh ReuvenDirectorDerivative conversion2026-03-17530,000
Wolfson MarinaChief Financial OfficerGrant / award2025-04-1468,545
Bassan MeravChief Development OfficerGrant / award2025-04-1479,597
Solomon Jonathan EitanChief Executive OfficerGrant / award2025-04-14126,748
Flynn James EDirectorOption exercise2025-02-27353,249
Oron AssafChief Business OfficerGrant / award2024-09-1625,804

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-03-17Yeganeh ReuvenDirectorDerivative conversion 530,000$2.00
2026-03-17Yeganeh ReuvenDirectorOpen market sale 530,000$5.00
2026-03-16Yeganeh ReuvenDirectorDerivative conversion 450,000$2.00
2026-03-16Yeganeh ReuvenDirectorOpen market sale 450,000$5.00
2026-03-13Yeganeh ReuvenDirectorDerivative conversion 370,000$2.00
2026-03-13Yeganeh ReuvenDirectorOpen market sale 370,000$5.00
2026-03-12Yeganeh ReuvenDirectorOpen market sale 300,000$5.00
2026-03-11Yeganeh ReuvenDirectorDerivative conversion 300,000$2.00
2025-04-14Wolfson MarinaChief Financial OfficerGrant / award 68,545$0.00
2025-04-14Bassan MeravChief Development OfficerGrant / award 79,597$0.00
2025-04-14Solomon Jonathan EitanChief Executive OfficerGrant / award 126,748$0.00
2025-02-27Flynn James EDirectorOption exercise 353,249$0.93
2025-02-27Flynn James EDirectorOption exercise 353,249$0.93

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 06:29 UTC

FiledFormReport periodOfficial filing
2026-10-198-K2026-10-13 View on SEC.gov →
2026-10-138-K2026-10-06 View on SEC.gov →
2026-10-078-K2026-10-07 View on SEC.gov →
2026-10-058-K2026-09-29 View on SEC.gov →
2026-09-298-K2026-09-29 View on SEC.gov →
2026-09-258-K2026-09-24 View on SEC.gov →
2026-09-228-K2026-09-16 View on SEC.gov →
2026-09-158-K2026-09-11 View on SEC.gov →
2026-09-098-K2026-09-03 View on SEC.gov →
2026-09-018-K2026-09-01 View on SEC.gov →
2026-08-288-K2026-08-28 View on SEC.gov →
2026-08-258-K2026-08-25 View on SEC.gov →

Headlines about HLSQ (Tessera Defense and Homeland Security Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist